Recent Quarter Total Invested
$568.21 M
Recent Quarter Institutional Ownership Percentage
110.66%
Total Invested of Last Quarter
$557.23 M
Ownership Percentage of Last Quarter
107.79%
KalVista Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VR ADVISER, LLC | 08/14/2024 | 6.25 M | $73.62 M | 0.00% | 14.34% |
TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 4.22 M | $49.70 M | 2.27% | 9.68% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2024 | 4.19 M | $49.38 M | 0.00% | 9.62% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 3.69 M | $43.44 M | 0.00% | 8.46% |
CAPITAL WORLD INVESTORS | 08/13/2024 | 3.23 M | $38.02 M | 120.37% | 7.40% |
BLACKROCK INC. | 08/13/2024 | 2.95 M | $34.69 M | 21.09% | 6.76% |
VESTAL POINT CAPITAL, LP | 08/14/2024 | 2.30 M | $27.09 M | 251.15% | 5.28% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 2.05 M | $24.15 M | -20.39% | 4.70% |
VANGUARD GROUP INC | 08/13/2024 | 1.99 M | $23.45 M | 18.13% | 4.57% |
BOXER CAPITAL, LLC | 08/14/2024 | 1.59 M | $18.73 M | 0.00% | 3.65% |
GREAT POINT PARTNERS LLC | 08/14/2024 | 1.34 M | $15.77 M | 100.00% | 3.07% |
SATURN V CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.13 M | $13.29 M | -21.74% | 2.59% |
FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 1.06 M | $12.48 M | -10.16% | 2.43% |
BIOIMPACT CAPITAL LLC | 08/14/2024 | 881,937 | $10.39 M | 15.93% | 2.02% |
DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 806,973 | $9.51 M | 0.00% | 1.85% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 806,271 | $9.50 M | 23.68% | 1.85% |
STATE STREET CORP | 08/14/2024 | 756,430 | $8.91 M | 27.31% | 1.74% |
STEMPOINT CAPITAL LP | 08/13/2024 | 736,765 | $8.68 M | -36.54% | 1.69% |
EMERALD ADVISERS, LLC | 08/06/2024 | 643,897 | $7.59 M | -4.06% | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 560,883 | $6.61 M | -0.05% | 1.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 535,717 | $6.31 M | -1.07% | 1.23% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 534,979 | $6.30 M | -7.71% | 1.23% |
EMERALD MUTUAL FUND ADVISERS TRUST | 08/06/2024 | 529,365 | $6.24 M | 0.00% | 1.21% |
PERCEPTIVE ADVISORS LLC | 08/16/2024 | 500,000 | $5.89 M | 0.00% | 1.15% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 467,998 | $5.51 M | 83.69% | 1.07% |
MORGAN STANLEY | 10/17/2024 | 338,584 | $3.99 M | -20.23% | 0.78% |
ROSALIND ADVISORS, INC. | 07/12/2024 | 337,985 | $3.98 M | 17.36% | 0.78% |
NORTHERN TRUST CORP | 08/14/2024 | 332,695 | $3.92 M | 4.66% | 0.76% |
CITIGROUP INC | 08/12/2024 | 286,064 | $3.37 M | 1.12% | 0.66% |
NAN FUNG GROUP HOLDINGS LTD | 08/13/2024 | 219,277 | $2.58 M | 0.00% | 0.50% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 212,888 | $2.51 M | 255.82% | 0.49% |
NICHOLAS INVESTMENT PARTNERS, LP | 08/08/2024 | 184,358 | $2.17 M | 0.94% | 0.42% |
JEFFERIES FINANCIAL GROUP INC. | 08/13/2024 | 175,000 | $2.06 M | 400.00% | 0.40% |
WOODLINE PARTNERS LP | 08/14/2024 | 150,462 | $1.77 M | 0.00% | 0.35% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 135,600 | $1.60 M | 21.01% | 0.31% |
NORGES BANK | 08/14/2024 | 131,300 | $1.55 M | 100.00% | 0.30% |
UBS OCONNOR LLC | 08/14/2024 | 122,960 | $1.45 M | 49.95% | 0.28% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 110,594 | $1.30 M | 41.54% | 0.25% |
D. E. SHAW & CO., INC. | 08/14/2024 | 100,061 | $1.18 M | 14.89% | 0.23% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 84,023 | $989,791 | 5.87% | 0.19% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 80,443 | $947,618 | 13.19% | 0.18% |
RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 78,682 | $926,873 | 100.00% | 0.18% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 08/15/2024 | 68,526 | $807,236 | 323.55% | 0.16% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 63,122 | $743,577 | -56.86% | 0.14% |
ZIMMER PARTNERS, LP | 08/14/2024 | 62,704 | $738,653 | -10.42% | 0.14% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 62,507 | $736,332 | 160.94% | 0.14% |
STATE OF WISCONSIN INVESTMENT BOARD | 08/14/2024 | 60,755 | $715,694 | 35.01% | 0.14% |
CLARIVEST ASSET MANAGEMENT LLC | 08/07/2024 | 57,096 | $672,591 | 2.76% | 0.13% |
FMR LLC | 08/13/2024 | 54,026 | $636,426 | 6.13% | 0.12% |
RHUMBLINE ADVISERS | 08/01/2024 | 53,228 | $627,016 | 12.49% | 0.12% |
KalVista Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of KALV shares?
During the previous two years, 141 institutional investors and hedge funds held shares of KalVista Pharmaceuticals, Inc.. The most heavily invested institutionals were:
AlphaCentric Advisors LLC: 0
Farther Finance Advisors, LLC: 0
INNEALTA CAPITAL, LLC: 0
VR Adviser, LLC: 6.25 M
TANG CAPITAL MANAGEMENT LLC: 4.22 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 4.19 M
-
What percentage of KalVista Pharmaceuticals, Inc. stock is owned by institutional investors?
110.66% of KalVista Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at KALV ?
Institutional investors have bought a total of 47.70 M shares in the last 24 months. This purchase volume represents approximately $536.67 M in transactions.